You have 9 free searches left this month | for more free features.

Anti-muscarinic treatment

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

Recruiting
  • Sjogren's Syndrome
  • Overactive Bladder Syndrome
  • Taichung, Taiwan
    China Medical University Hospital
Aug 8, 2021

Pulmonary Disease, Chronic Obstructive Trial in New Zealand, Thailand, United Kingdom (400 microgrammes GSK961081, 1200

Completed
  • Pulmonary Disease, Chronic Obstructive
  • 400 microgrammes GSK961081
  • 1200 microgrammes GSK961081
  • Wellington, New Zealand
  • +3 more
Sep 28, 2021

Asthma Trial (Glycopyrronium bromide 25ug, Placebo, Glycopyrronium bromide 12.5ug)

Recruiting
  • Asthma
  • Glycopyrronium bromide 25ug
  • +2 more
  • Ruse, Bulgaria
  • +11 more
Jan 23, 2023

Urinary Bladder, Overactive Trial in Denizli (Transcutaneous tibial nerve stimulation (TTNS))

Not yet recruiting
  • Urinary Bladder, Overactive
  • Transcutaneous tibial nerve stimulation (TTNS)
  • Denizli, Turkey
    Pamukkale University
Dec 19, 2022

Urinary Bladder, Overactive Trial (intravaginal electrical stimulation added to bladder training)

Recruiting
  • Urinary Bladder, Overactive
  • intravaginal electrical stimulation added to bladder training
  • Denizli, Turkey
    Pamukkale Univercity
Oct 31, 2022

COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as

Completed
  • Chronic Obstructive Pulmonary Disease
  • Los Angeles, California
  • +82 more
Oct 28, 2022

COPD Trial in Groningen, Leeuwarden (Tiotropium Bromide)

Recruiting
  • COPD
  • Tiotropium Bromide
  • Groningen, Netherlands
  • +1 more
Jul 19, 2022

Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition Trial in Mainz (Immunoadsorption, Sham-apheresis)

Recruiting
  • Post-COVID-19 Syndrome
  • +2 more
  • Immunoadsorption
  • Sham-apheresis
  • Mainz, Rheinland-Pfalz, Germany
    UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
May 2, 2023

Penehyclidine, Postoperative Nausea and Vomiting, Bimaxillar Surgery Trial in Beijing (Single injection of penehyclidine,

Completed
  • Penehyclidine
  • +2 more
  • Single injection of penehyclidine
  • +2 more
  • Beijing, China
    Peking Univeristy Hospital Stomatology
Sep 14, 2021

COPD, Lower Respiratory Disease Trial in New York (Cardio-Pulmonary Exercise Testing (CPET))

Completed
  • Chronic Obstructive Pulmonary Disease
  • Lower Respiratory Disease
  • Cardio-Pulmonary Exercise Testing (CPET)
  • New York, New York
    New York University School of Medicine
Jan 7, 2022

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Multiple Sclerosis Trial in London (PIPE-307)

Completed
  • Multiple Sclerosis
  • London, United Kingdom
    Hammersmith Medicines Research
Oct 4, 2022

Schizophrenia Trial in Boston (CVL-231)

Recruiting
  • Schizophrenia
  • Boston, Massachusetts
    Massachusetts General Hospital Translational and Clinical Resear
Jul 6, 2022

Pulmonary Disease, Chronic Obstructive Trial in London (GSK961081, GSK961081 matching )

Completed
  • Pulmonary Disease, Chronic Obstructive
  • London, United Kingdom
    GSK Investigational Site
Sep 28, 2021

Traumatic Brain Injury Trial in Sao Paulo (Biperiden Lactate, Placebo)

Recruiting
  • Traumatic Brain Injury
  • Biperiden Lactate
  • Placebo
  • Sao Paulo, Brazil
    Federal University of São Paulo
Jun 17, 2021

Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Recruiting
  • Takayasu's Arteritis
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    A Retrospective rEal-life daTa Study to Assess exaceRbations and

    Completed
    • COPD
    • COPD Exacerbation
      • Thessaloniki, Greece
        Papanikolaou Hospital of Thessaloniki
      Sep 7, 2022

      Myocardium; Injury, Myocardial Infarction, Myocardial Ischemia Trial in Rawalpindi (Colchicine, Placebo oral tablet)

      Suspended
      • Myocardium; Injury
      • +2 more
      • Rawalpindi, Pakistan
        Rawalpindi Institute of Cardiology
      Dec 9, 2021

      Toxic Effect of Organophosphate and Carbamate Insecticides Trial in High Point (Atropine Sulfate Ophthalmic Solution, Atropine

      Completed
      • Toxic Effect of Organophosphate and Carbamate Insecticides
      • Atropine Sulfate Ophthalmic Solution
      • Atropine Sulphate Injection
      • High Point, North Carolina
        High Point Clinical Trials Center
      Jul 20, 2021

      Asthma in Children Trial in Jacksonville (Tiotropium Bromide)

      Not yet recruiting
      • Asthma in Children
      • Tiotropium Bromide
      • Jacksonville, Florida
        Nemours Specialty Care
      Aug 3, 2021

      Depression, Anxiety, Stress Trial in Abbottabad (Lemon Balm Supplement, Matched Placebo)

      Recruiting
      • Depression
      • +3 more
      • Lemon Balm Supplement
      • Matched Placebo
      • Abbottābād, Pakistan
        Ayub Teaching Hospital
      Jan 4, 2023

      COPD Trial in Miami (Bevespi, Bretzri)

      Recruiting
      • Chronic Obstructive Pulmonary Disease
      • Miami, Florida
        University of Miami
      Jan 23, 2023

      COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)

      Active, not recruiting
      • Chronic Obstructive Pulmonary Disease
      • Dupilumab SAR231893
      • +4 more
      • Andalusia, Alabama
      • +286 more
      May 11, 2022

      Chronic Obstructive Pulmonary Disease (COPD) Participants

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • prospective observational cohort study
      • Hannover, Niedersachsen, Germany
        GSK Investigational Site
      Jun 20, 2022

      Myopia Trial in Kowloon (0.01% atropine eye drops, ortho-k)

      Completed
      • Myopia
      • 0.01% atropine eye drops
      • ortho-k
      • Kowloon, Hong Kong
        School of Optometry, The Hong Kong Polytechnic University
      Aug 6, 2021